Avantor Inc

Avantor Inc

AVTR · NYSE · Healthcare / Medical Instruments & Supplies

15.54USD-0.08 (-0.51%)

Price History

Full chart

Market Stats

Previous Close15.62
Open15.63
Day Range15.44 – 15.70
52-Week Range7.27 – 16.05
Volume6.82M
Market Cap10.40B
P/E (TTM)0.00
Forward P/E16.86
EPS-0.85
Dividend Yield0.00%
Beta0.90
50-Day Avg13.78
200-Day Avg10.59

About

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Emmanuel Ligner
  • Employees13.50K
  • HeadquartersRadnor Corporate Center, Radnor, PA, United States, 19087, USA
  • Websitehttps://www.avantorsciences.com

Leadership

  • Mr. Emmanuel LignerPresident, CEO & Director · b. 1971
  • Mr. Claudius O. SokenuExecutive VP, Corporate Secretary and Chief Legal & Compliance Officer · b. 1968
  • Mr. Corey D. WalkerPresident of Laboratory Solutions · b. 1978
  • Mr. Benoit GourdierExecutive Vice President of Bioscience Production · b. 1967
  • Ms. Mary BlennExecutive VP & COO

Financials

Income Statement

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue636.90M691.30M1.25B5.86B6.04B6.39B7.39B4.91B6.97B6.78B6.55B
Growth (%)-+8.54%+80.44%+370.12%+3.00%+5.85%+15.52%-33.53%+41.91%-2.64%-3.41%
Cost of Revenue374.70M371.60M814.60M4.04B4.12B4.31B4.88B2.31B4.60B4.50B4.41B
Gross Profit262.20M319.70M432.80M1.82B1.92B2.08B2.50B2.60B2.36B2.28B2.14B
Gross Margin41.17%46.25%34.70%31.03%31.80%32.54%33.88%53.01%33.93%33.60%32.65%
Operating Expense201.90M309.80M643.20M1.41B1.37B1.37B1.53B1.47B1.67B1.19B2.39B
Operating Income60.30M9.90M-210.40M413.50M551.80M706.80M972.20M1.13B696.40M1.08B-246.20M
Operating Margin9.47%1.43%-16.87%7.05%9.14%11.05%13.16%23.02%10.00%15.99%-3.76%
EBITDA121.10M70.00M-160.10M814.60M879.50M765.30M1.35B1.53B1.10B1.48B138.70M
EBITDA Margin19.01%10.13%-12.83%13.89%14.56%11.97%18.27%31.26%15.75%21.79%2.12%
Net Income21.60M-42.40M-112.70M-86.90M37.80M116.60M572.60M686.50M321.10M711.50M-530.20M
Net Income Margin3.39%-6.13%-9.03%-1.48%0.63%1.82%7.75%13.98%4.61%10.49%-8.09%
R&D21.90M19.10M---------
R&D as % of Total Revenue3.44%2.76%---------
Interest Expense080.30M200.90M523.80M440.00M307.60M217.40M265.80M284.80M218.80M169.80M
Interest Expense % of Total Revenue0.00%11.62%16.11%8.93%7.28%4.81%2.94%5.41%4.09%3.23%2.59%

Balance Sheet

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-1.14B10.45B9.91B9.77B9.91B13.90B13.46B12.97B12.11B11.79B
Total Liabilities-1.65B13.07B12.96B7.31B7.23B9.70B8.61B7.72B6.16B6.23B
Total Equity--374.90M-2.62B-3.05B2.46B2.67B4.20B4.86B5.25B5.96B5.57B
Cash-62.90M185.40M184.70M186.70M286.60M301.70M372.90M262.90M261.90M365.40M
Total Debt-1.30B7.12B6.92B5.12B4.89B7.02B6.29B5.54B4.06B3.95B
Net Debt-1.23B6.93B6.74B4.93B4.61B6.72B5.91B5.27B3.79B3.58B

Cash Flow

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow124.60M72.90M-167.50M200.50M354.00M929.80M953.60M843.60M870.00M840.80M623.80M
Investing Cash Flow-35.40M-29.90M-6.68B-23.20M-42.10M-59.10M-4.12B-109.60M-143.70M438.90M-130.50M
Financing Cash Flow-87.60M-43.50M6.96B-170.30M-307.80M-782.90M3.22B-648.70M-843.70M-1.28B-409.40M
Capital Expenditure20.90M29.90M25.20M37.70M51.60M61.60M111.10M133.40M146.40M148.80M128.80M
Free Cash Flow103.70M43.00M-192.70M162.80M302.40M868.20M842.50M710.20M723.60M692.00M495.00M
Dividends Paid2.30M158.70M1.70B31.30M31.30M64.60M64.60M32.40M18.30M0-
FCF to OCF83.23%58.98%115.04%81.20%85.42%93.37%88.35%84.19%83.17%82.30%79.35%
Dividend Paid to FCF2.22%369.07%-883.19%19.23%10.35%7.44%7.67%4.56%2.53%0.00%-

Earnings

Report DateDec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019May 20, 2019Aug 6, 2019Nov 5, 2019Feb 7, 2020Apr 29, 2020Jul 29, 2020Oct 27, 2020Feb 3, 2021Apr 28, 2021Jul 29, 2021Oct 28, 2021Feb 3, 2022Apr 28, 2022Jul 28, 2022Oct 28, 2022Feb 3, 2023Apr 28, 2023Jul 28, 2023Oct 27, 2023Feb 14, 2024Apr 26, 2024Jul 26, 2024Oct 25, 2024Feb 7, 2025Apr 25, 2025Aug 1, 2025Oct 29, 2025Feb 11, 2026Apr 29, 2026Jul 29, 2026Nov 4, 2026
EPS Estimate0.000.000.000.000.000.000.270.170.150.160.140.140.210.260.280.310.320.330.360.380.330.300.290.290.250.220.200.230.250.260.230.250.230.220.160.190.21
EPS Actual-2.84-0.79-0.70-0.26-0.94-0.59-0.180.140.150.190.170.190.240.290.350.350.350.360.380.370.340.320.290.280.250.250.220.250.260.270.230.240.220.220.170.21-
Surprise-------166.67%-17.65%0.00%18.75%21.43%35.71%14.29%11.54%25.00%12.90%9.38%9.09%5.56%-2.63%3.03%6.67%0.00%-3.45%0.00%13.64%10.00%8.70%4.00%3.85%0.00%-4.00%-4.35%0.00%6.25%10.53%-
Timing------After-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap10.40B
Enterprise Value13.37B
Trailing P/E0.00
Forward P/E16.86
Price / Sales1.59
Price / Book1.77
EPS-0.85
Book Value8.32
Revenue (TTM)6.56B
Gross Profit (TTM)2.09B
EBITDA943.70M
Profit Margin-8.81%
Operating Margin7.16%
Return on Equity-9.70%
Return on Assets2.69%
Shares Outstanding676.36M
Shares Float657.81M
Beta0.90
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 21 analystsTarget 14.66
  • Strong Buy
    6
  • Buy
    4
  • Hold
    11

Ownership Breakdown

Institutions
105.34%
Insiders
1.52%
Retail / Other
0.00%

Top Institutional Holders

  • Dodge & Cox
    120.02M17.75%
  • BlackRock Inc
    65.70M9.71%
  • Vanguard Portfolio Management, LLC
    31.28M4.62%
  • Vanguard Capital Management, LLC
    30.61M4.53%
  • Greenhaven Associates Inc
    24.64M3.64%
  • State Street Corp
    20.72M3.06%
  • Dimensional Fund Advisors, Inc.
    20.41M3.02%
  • Engine Capital Management LP
    19.86M2.94%
  • Barrow Hanley Mewhinney & Strauss LLC
    19.74M2.92%
  • T. Rowe Price Investment Management,Inc.
    14.79M2.19%
  • New Mountain Capital, L.L.C.
    14.00M2.07%
  • Geode Capital Management, LLC
    12.89M1.91%
  • London Company of Virginia
    10.85M1.60%
  • Fuller & Thaler Asset Management Inc
    10.63M1.57%

Top Fund Holders

  • Dodge & Cox Stock I
    74.87M11.07%
  • iShares Core S&P Mid-Cap ETF
    23.91M3.54%
  • Vanguard MStar Total Stk Mkt Idx Invest
    21.73M3.21%
  • Vanguard Small Cap Index
    15.71M2.32%
  • Bridge Builder Large Cap Value
    12.36M1.83%
  • Vanguard MStar Small Cap Value Index
    9.98M1.48%